Safety and Efficacy Evaluation of Topical AL-60371 Otic Suspension, 0.3% in the Treatment of Acute Otitis Externa
Status:
Completed
Trial end date:
2012-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study was to demonstrate superiority of AL-60371 relative to Vehicle
based on clinical cures at test-of-cure (TOC) for the treatment of acute otitis externa
(AOE).